Skip to content

LUTONIX® Drug Coated Balloon LX357561205FRecalls & reported problems

Lutonix, Inc. · LUTONIX® 035 Drug Coated Balloon PTA Catheter .035" 75cm 6x120mm 5 French · Class 3

All models of LUTONIX Drug Coated Balloon (107)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741122903), received between Jul 16, 2019 and Jul 16, 2019 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Reocclusion1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 16, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THROUGH A POST MARKET CLINICAL STUDY THAT A LUTONIX DRUG COATED BALLOON (DCB) DILATATION CATHETER WAS USED TO TREAT THE RIGHT FEMORAL ARTERY. IT WAS FURTHER REPORTED THAT APPROXIMATELY 9-MONTH POST PROCEDURE, REOCCLUSION WAS IDENTIFIED IN THE TARGET LESION AND A REVASCULARIZATION WAS PERFORMED SUCCESSFULLY. THE INVESTIGATOR DETERMINED THAT THE EVENT WAS POSSIBLY RELATED TO THE PROCEDURE, BUT NOT RELATED TO THE STUDY DEVICE.

    Patient problems: Reocclusion

    MAUDE report 8795743 ↗

Other Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices

All Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page